Dietary antioxidant supplements: benefits of their combined use by Almeida, Ivone M.C. et al.
Dietary antioxidant supplements: benefits of their combined use 
 
 
Ivone M.C. Almeida
a
, João C.M. Barreira
a,b
, M. Beatriz P.P. Oliveira
a
,  
Isabel C.F.R. Ferreira
b,*
 
 
 
a
REQUIMTE/ Depto. de Ciências Químicas, Faculdade de Farmácia, Universidade do 
Porto, Rua de Aníbal Cunha, 164, 4050-047 Porto, Portugal 
b
CIMO-ESA, Instituto Politécnico de Bragança Campus de Santa Apolónia, Apartado 
1172, 5301-855 Bragança, Portugal. 
 
 
 
 
*Author to whom correspondence should be addressed (I.C.F.R. Ferreira: 
iferreira@ipb.pt, tel. +351-273303219, fax +351-273325405). 
Abstract 
Several dietary supplements claim medicinal benefits due to their composition in 
hydrophilic and lipophilic molecules, natural extracts or synthetic compounds with 
antioxidant properties. In the present work, the antioxidant activity of selected 
supplements taken in pills, capsules or infusions were studied either individually or 
combined. Linear discriminant analysis (LDA) was used to categorize the condensed 
formulations (pills and capsules), infusion bags and combined samples according with 
their antioxidant activity measured by radical scavenging activity, reducing power and 
lipid peroxidation inhibition using brain homogenates as models. AAF proved to have 
the highest antioxidant activity in all the assayed methods, either singly taken or 
included in mixtures. Furthermore, the mixtures containing this supplement revealed 
synergistic effects in 92% of the cases. The intake of antioxidant mixtures might 
provide some additional benefits.  
 
Keywords: Dietary Supplements; Antioxidant activity; Synergistic Effects; Linear 
Discriminant Analysis 
 
1. Introduction 
In living systems, Reactive Oxygen/Nitrogen Species (ROS/ RNS) are produced 
primarily during normal aerobic metabolism (Halliwell and Gutteridge, 2007). At 
physiological levels, these intermediates participate in numerous metabolic processes 
including cell signalling, energy production, gene transcription and immune defence, 
among others (Seifried et al., 2007). However, decline of antioxidant defence 
mechanisms or exposure to environmental factors (smoke, pollution, ultraviolet 
radiation, high-fat diet, etc.) and pathological conditions (chronic infection, 
inflammation, etc.) can lead to increased ROS/RNS production, resulting in oxidative 
stress (Valko, et al., 2007). Oxidative stress can damage key organic substrates such as 
DNA, lipids and proteins, compromising cells physiological function (Nordberg and 
Arnér, 2001). This condition has been associated to the ageing process in general, and to 
the initiation and progression of a variety of chronic conditions related to it, such as 
cardiovascular disease and cancer (Valko et al., 2007).  
Protection against ROS/RNS-induced damage is provided by complex antioxidant 
defence systems, comprising endogenous enzymatic and non-enzymatic antioxidants 
(e.g., superoxide dismutase, catalase, glutathione peroxidase  and glutathione reductase) 
and exogenous antioxidants (e.g., vitamin C, vitamin E, carotenoids and polyphenols), 
the latter provided mainly by the diet (Young and Woodside, 2001). Indeed, numerous 
epidemiological and clinical studies have linked high intake of fruits, vegetables, whole 
grains, and beverages of plant origin, which are rich in antioxidants, with lower 
incidence and mortality rates of chronic diseases including diabetes, atherosclerosis, 
rheumatoid arthritis, neurodegenerative and coronary diseases and cancer (Cerhan et al., 
2003; de Kok et al., 2010; Esposito et al., 2002; Ford and Mokdad, 2001; Hertog et al.; 
1993, Kris-Etherton et al., 2003). These potential physiological benefits of dietary 
antioxidants have lead, in recent years, to a dramatic growth of the market of functional 
foods and dietary supplements claiming “antioxidant power”, and to the widespread 
consumption of these products.  
Antioxidant dietary supplements are sold as isolated substances or as mixtures, from 
natural or synthetic origin, and are presented in a variety of forms including tablets, 
pills, capsules, powders, drinks and supplement bars. Antioxidant formulations use a 
plethora of ingredients, including antioxidant vitamins (tocopherols, ascorbic acid), 
bioactive compounds of plant origin (polyphenols and carotenoids), plant and algae 
extracts, fruits and vegetables concentrates, enzymes, minerals (selenium, zinc, 
manganese), polysaccharides, organosulfur compounds, etc.  
The antioxidant activity of foodstuffs as well as the purified bioactive compounds to be 
used in supplement formulations, has been intensely researched (Barreira et al., 2008; 
Borges et al., 2010; Gorinstein et al., 2011; Müller et al., 2011; Stratil et al., 2007; 
Tabart et al., 2009). However, data regarding antioxidant activity of formulations 
already on the market is scarce. These products are promoted has antioxidant boosters 
but labels often lack information regarding effective antioxidant capacity values.  
Therefore, the present study aimed to evaluate the antioxidant activity of different 
commercial antioxidant dietary supplements available in Portuguese market, by three in 
vitro assays: scavenging activity against 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
radicals, reducing power, and inhibition of lipid peroxidation using TBARS in brain 
homogenates. Moreover, some of the samples were mixed and further assayed in search 
of synergistic effects. 
 
2. Materials and methods 
2.1. Standards and reagents 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA, 
USA). Standards trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) and 
-tocopherol were purchased from Sigma (St. Louis, MO, USA). Methanol and all 
other chemicals were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Water 
was treated in a Mili-Q water purification system (TGI Pure Water Systems, USA). 
 
2.2. Samples and samples preparation 
Samples were dietary supplements commercially available and labeled with antioxidant 
potential. In order to confirm and compare their antioxidant activity, the samples were 
prepared using the formulation available: pill, capsule or bag (Table 1). Each 
formulation was weighted and dissolved in 200 mL of distilled water in order to obtain 
the concentration of the stock-solution. Pills and the inner part of the capsules were 
dissolved in distilled water, while bags were used to prepare infusions. Several dilutions 
of each sample were prepared to perform the antioxidant activity assays. 
Some of the samples were mixed and further assayed in search of synergistic effects. 
Four mixtures were prepared: AAF+Res+EMCO (stock-solution 4.56 mg/mL) and the 
corresponding binary combinations: AAF+Res (stock-solution 3.60 mg/mL), 
AAF+EMCO (stock-solution 5.11 mg/mL) and Res+EMCO (stock-solution 4.99 
mg/mL). 
 
2.3. Antioxidant activity assays 
2.3.1. General 
The antioxidant activity of the individual and mixed samples was evaluated by DPPH 
radical-scavenging activity, reducing power and inhibition of lipid peroxidation using 
TBARS in brain homogenates. The sample concentrations providing 50% of antioxidant 
activity or 0.5 of absorbance (EC50) were calculated from the graphs of antioxidant 
activity percentages (DPPH and TBARS assays) or absorbance at 690 nm (reducing 
power assay) against sample concentrations. The concentrations range was defined in 
order to allow percentages of antioxidant activity from ~10 to ~90% (sock-solution and 
successive dilutions).  Trolox and -tocopherol were used as standards. 
 
2.3.2. DPPH radical-scavenging activity 
This methodology was performed using an ELX800 Microplate Reader (Bio-Tek 
Instruments, Inc). The reaction mixture on 96 wells plate consisted of a solution by well 
of the different samples concentrations (30 μL) and methanolic solution (270 μL) 
containing DPPH radicals (610-5 mol/L). The mixture was left to stand for 30 min in 
the dark. The reduction of the DPPH radical was determined by measuring the 
absorption at 515 nm (Guimarães et al., 2010). The radical scavenging activity (RSA) 
was calculated as a percentage of DPPH discolouration using the equation: % RSA = 
[(ADPPH-AS)/ADPPH]  100, where AS is the absorbance of the solution containing the 
sample, and ADPPH is the absorbance of the DPPH solution.  
 
2.3.3. Reducing power 
The different concentrations of the samples solutions (0.5 mL) were mixed with sodium 
phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 
0.5 mL). The mixture was incubated at 50 ºC for 20 min, and trichloroacetic acid (10% 
w/v, 0.5 mL) was added. The mixture (0.8 mL) was poured in the 48 wells plate, as also 
deionised water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the absorbance 
was measured at 690 nm in the Microplate Reader described above (Guimarães et al., 
2010). 
 2.3.4. Inhibition of lipid peroxidation using thiobarbituric acid reactive substances 
(TBARS) 
Brains were obtained from pig (Sus scrofa), dissected, and homogenized with a 
Polytron in ice cold Tris-HCl buffer (20 mM, pH 7.4) to produce a 1:2 w/v brain tissue 
homogenate which was centrifuged at 3000g for10 min. An aliquot (0.1 mL) of the 
supernatant was incubated with the different concentrations of the samples solutions 
(0.2 mL) in the presence of FeSO4 (10 mM; 0.1 mL) and ascorbic acid (0.1 mM; 0.1 
mL) at 37 ºC for 1 h. The reaction was stopped by the addition of trichloro acetic acid 
(28% w/v, 0.5 mL), followed by thiobarbituric acid (TBA,2%, w/v, 0.38 mL), and the 
mixture was then heated at 80 ºC for 20 min. After centrifugation at 3000g for 10 min to 
remove the precipitated protein, the colour intensity of the malondialdehyde (MDA)-
TBA complex in the supernatant was measured by its absorbance at 532 nm (Ng et al., 
2000). The inhibition ratio (%) was calculated using the following formula: Inhibition 
ratio (%) = [(A - B)/A] × 100%, where A and B were the absorbance of the control and 
the sample solution, respectively.  
 
2.4. Statistical analysis 
All the assays were carried out in triplicate in three different samples of each single 
supplement. The results are expressed as mean valuestandard deviation (SD). The 
statistical differences represented by letters were obtained through one-way analysis of 
variance (ANOVA) followed by Tukey’s honestly significant difference post hoc test 
with α = 0.05, coupled with Welch’s statistic. The homoscedasticity of distribution was 
checked through Levene’s test. 
In addition, a linear discriminant analysis (LDA) was used as a supervised learning 
technique to classify the assayed antioxidant dietary supplements according to their 
antioxidant activity results. A stepwise technique, using the Wilks’ λ method with the 
usual probabilities of F (3.84 to enter and 2.71 to remove), was applied for variable 
selection, verifying which canonical discriminant functions were significant. To avoid 
overoptimistic data modulation, a leaving-one-out cross-validation procedure was 
carried out to assess the model performance.  
Moreover, the sensibility and specificity of the discriminant model were computed from 
the number of individuals correctly predicted as belonging to an assigned group (López 
et al., 2008; Rencher, 1995). Sensibility was calculated by dividing the number of 
samples of a specific group correctly classified by the total number of samples 
belonging to that specific group. Specificity was calculated by dividing the number of 
samples of a specific group classified as belonging to that group by the total number of 
samples of any group classified as belonging to that specific group. LDA statistical 
analysis and the other statistical tests were performed at a 5% significance level using 
the SPSS software, 18.0 (SPSS Inc). 
 
3. Results and discussion 
The composition of the assayed dietary supplements is described in Table 1. Their 
selection was based in the different components included in the available formulations, 
either as single active components or in different combinations. The antioxidant 
components comprise lipophilic (e.g. vitamin E and β-carotene) and hydrophilic (e.g. 
vitamin C and polyphenols) molecules, natural extracts (e.g. Ginkgo biloba and Mentha 
spicata) or synthetic compounds (e.g. sodium selenite and zinc sulphate).  
A wide range of methods have been used to screen the in vitro antioxidant capacity of 
foods and dietary supplements (Antolovich et al., 2002; Dávalos et al., 2005; Prior and 
Cao, 2000; Moon and Shibamoto, 2009). Standard procedures regarding antioxidant 
capacity methods have been recommended (Dávalos et al., 2005; Frankel and Meyer, 
2000; Frankel and Finley, 2008; Prior and Cao, 1999), but this issue is still matter of 
debate. 
Herein, three in vitro assays: scavenging activity against DPPH radicals, reducing 
power, and inhibition of lipid peroxidation using TBARS in brain homogenates were 
applied to evaluate the antioxidant activity of dietary supplements commercialized in 
Portugal. 
Table 2 gives the results obtained for the antioxidant activity of individual and 
combined samples. As expected, results regarding antioxidant activity of the different 
commercial dietary antioxidant supplements show great variability, reflecting their 
diverse composition and concentrations.  
Considering DPPH scavenging activity, AAF (0.0520.001 mg/mL) and SACE 
(0.120.02 mg/mL) were the most powerful supplements; regarding TBARS inhibition, 
AAF (0.0320.003 mg/mL), VB (0.0470.002 mg/mL), Pyc (0.0470.001 mg/mL), AA 
(0.0490.004 mg/mL), Res (0.0510.001 mg/mL) and BAPN (0.0710.005 mg/mL) 
achieved the best results; in the case of reducing power, SACE (0.03370.0004 
mg/mL), AAF (0.0420.005 mg/mL), VB (0.04360.0005 mg/mL) and AA 
(0.06140.0005 mg/mL) revealed the highest antioxidant activity. In general, the 
obtained results confirmed the antioxidant potential of the assayed supplements, and 
some EC50 values are similar to those obtained with reference standards like -
tocopherol or trolox (table 2). 
The net effect of dietary antioxidants on health depends on intake levels, bioavailability, 
ability to scavenge ROS/RNS and synergistic effects (Liu, 2004; Manach, et al., 2005). 
It´s well accepted that a cooperative mix of antioxidants in a balanced form appears to 
be more effective than high levels of one or a few antioxidants (Liu, 2004; Wang et al., 
2011). Therefore, four mixtures were assayed in search of synergistic effects: 
AAF+Res+EMCO and the corresponding binary combinations: AAF+Res, 
AAF+EMCO and Res+EMCO. Since some of the assayed supplements already contain 
several components, it was decided to include an infusion to avoid the unique use of 
pharmaceutical formulations. Besides, infusions are apparently better accepted by the 
consumers. EMCO was chosen due to its highest antioxidant activity among infusions. 
Furthermore, the sample that showed the highest antioxidant activity (AAF) was also 
included. Res was chosen in order to evaluate the influence of an antioxidant 
supplement which is composed mainly by a single molecule. 
The types of interactions (synergistic, additive or antagonist) observed in the 
antioxidant activity of the dietary supplements mixtures are given in Table 3. For 
DPPH radical scavenging activity, as well as for reducing power assays, the mixtures 
were always synergistic (increase of antioxidant capacity). The synergistic effect 
predominated also in the TBARS inhibition assay, being observed in 75% of the 
mixtures; AAF+Res demonstrated an additive effect.  
The results were also analyzed through LDA to evaluate if the observed differences 
were sufficient to differentiate the condensed dietary supplements (pills and capsules) 
from the bags formulations (infusions). All independent variables selected by the 
stepwise procedure of the discriminant analysis were statistically significant according 
to the Wilks’λ test (P < 0.05). The stepwise LDA was performed considering the results 
obtained in all the assayed antioxidant methods, ensuing in a discriminant model with 
two significant (P < 0.001 for the Wilks’ λ test) discriminant functions. These functions 
explained 100.0% of the variance of the experimental data (the first explained 71.2% 
and the second 28.8%. The first function (Figure 1) revealed to be more powerfully 
correlated with DPPH scavenging activity, while TBARS inhibition was the most 
important variable for function 2. The model showed a satisfactory classification 
performance allowing to correctly classifying 70.8% of the samples for the original 
groups as well as for the cross-validation procedure. This separation is clearer in the 
case of infusion bags, demonstrating that the assayed combinations permitted to obtain 
mixtures with antioxidant potential more related with the condensed formulas (pills and 
capsules) than with the included infusion samples (bags). 
 
Overall, AAF proved to have the highest antioxidant activity in all the assayed methods, 
providing the best results, either singly taken or included in mixtures. Furthermore, the 
mixtures containing this supplement revealed synergistic effects in 92% of the cases. 
The intake of antioxidant mixtures might provide some additional benefits, since the 
same antioxidant activity can be achieved with lower amounts of the chemical 
compounds included in the pills or capsules. For the assayed combinations, the 
synergistic interaction was the main observed effect. Regarding LDA, the assayed 
dietary antioxidant supplements proved to have distinctive features, derived from being 
condensed (pills or capsules) or bags (infusions) formulas. Furthermore, it is relatively 
clear that the tested combinations retain an antioxidant profile highly similar to the 
presented by the condensed formulas included in those mixtures.  
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 Table 1. Composition of the dietary supplements and concentrations of the stock-solution of each sample.  
Sample Composition Formulation Recommended Daily Dose Stock solution
a
 (mg/mL) 
SACE 
Disodium selenium (0.056%), vitamins A (retinol acetate: 0.74%), C (L-
ascorbic acid: 22.5%) and E (α-tocopherol: 15%) 
Pill (397 mg) 1 pill 1.98 
S200 Selenium: 200 μg, brewer’s yeast Pill (614 mg) 1 pill 3.07 
VB 
Vitamins A, C (L-ascorbic acid) and E (D-α-tocopherol succinate), 
broccoli sprouts powder, red fruit (grape, blueberry, cranberry, cherry, 
strawberry and raspberry) combined extract, selenium (yeast). 
Pill (578 mg) 1 pill 2.89 
BAPN 
Vitamins A (retinol: 864 μg), B1 (thiamine: 1.8 mg), B2 (riboflavine: 2.8 
mg), B3 (nicotinamide), B5 (pantothenic acid: 7.5 mg), B6 (pyridoxine), 
B7 (biotin: 100 μg), B11 (folacin: 200 μg), B12 (cyanocobalamin: 4.5 
μg), C (ascorbic acid: 200 mg), D (calcipherol: 2.5 μg) and E (D-α-
tocopherol: 30 mg), magnesium (75 mg), zinc (7.5 mg), Selenium (L-
selenomethionine: 62.5 μg), chromium (yeast: 50 μg),  manganese (2.5 
mg), copper (1 mg) 
Pill (1058 mg) 1 pill 5.29 
LLSC 
Soy isoflavones, vitamin C, Lycopersicon esculentum extract, 
lactoproteins, soy lecitin, Lacto-licopene 
Pill (737 mg) 2 pills 3.68 
KAG 
Aged garlic extract, Sylibum marianum extract, green tea (powder), 
vitamins A (β-carotene), C (L-ascorbic acid) and E (α-tocopherol 
succinate), grape seed extract, pine bark extract, selenium (L-
selenomethionine) 
Capsule (431 mg) 4 capsules 2.16 
SZCEA 
Sodium selenite (0.02%), zinc sulphate (4.8%), vitamins A (β-carotene: 
7.5%), C (calcium L-ascorbate: 12%) and E (D-α-tocopherol acetate: 
12%) 
Capsule (374 mg) 1 capsule 1.87 
AAF 
Vitamins A (β-carotene: 4.5 mg), C (calcium L-ascorbate: 500 mg) and E 
(D-α-tocopherol succinate: 134 mg and other tocopherols: 20 mg), L-
cysteine chloridrate; food based antioxidants: powdered extracts of green 
tea (7.5 mg of polyphenols), red wine (4.5 mg of polyphenols) and 
Pycnogenol (3 mg of procyanidins), zinc glycinate (10 mg), taurine (50 
mg), L-glutathione (50 mg), manganese glycinate (4 mg),powdered 
Capsule (744 mg) 2 capsules 3.72 
active plant base (Spirulina, Ginkgo biloba, Sylibum marianum and Gotu 
kola extracts), selenomethionine (50 μg), copper lysinate (1 mg) and 
riboflavin-5-phosphate (6 mg) 
Pyc Pycnogenol (Pinus maritima bark extract): 30 mg Capsule (247 mg) 1-2 capsules 1.24 
Res Resveratrol(Polygonum cuspidatum root extract): 200 mg Capsule (695 mg) 1-2 capsules 3.48 
GC Coffee arabica seeds (whole cryogrinded powder): 1% caffeine Capsule (288) 2 capsules/day 1.44 
AA 
Vitamin C (L-ascorbic acid) and E (α-tocopherol: 50%), green tea 
powder, rosemary leaf powder, grape extract, propolis alcoholic extract, 
Pinus albicaulis 
Capsule (220 mg) 2 capsules 1.10 
GBGT 
Vitamin A (retinol acetate: 0.083%), C (L-ascorbic acid: 13.9%) and E 
(D-α-tocopherol: 5.6%), Lycopersicum esculentum fruit: 6.9%, Gingko 
biloba leaves (6.9%), Camelia sinensis (green tea): 1.9%; β-carotene: 
0.7%.  
Capsule (650 mg) 2 capsules 3.25 
GM Mangosteen 10:1 (Garcinia mangostana) Capsule (848 mg) 2 capsules 4.24 
VRFR 
Vitis vinifera (red vine leaves: 35%), Hibiscus sabdariffa (flowers: 25%),  
Pyrus malus (fruit: 16%), orange and red fruits natural flavors 
Bag (1500 mg) 1-3 teacups 7.50 
EA Equisetum arvense  Bag (1300 mg) 2-3 teacups 6.5 
EMCO 
Equisetum arvense (30%), Olea europaea (30%), Crataegus laevigata 
(20%), Mentha piperita (20%) 
Bag (1300 mg) 2-3 teacups 6.5 
 
aPills and the inner part of the capsules were dissolved in 200 mL of distilled water; bags were used to prepare infusions using the same volume 
of distilled water.
Table 2. Antioxidant activity of individual and combined samples of dietary supplements. In each column different letters mean significant 
differences (p0.05). 
Sample 
DPPH scavenging 
activity EC50 (mg/mL)  
Reducing power 
EC50 (mg/mL) 
TBARS inhibition 
EC50 (mg/mL) 
SACE 0.12±0.02 l 0.0337±0.0004 i 1.9±0.1 b 
S200 2.9±0.1 c 2.96±0.05 b 2.8±0.1 a 
VB 0.36±0.02 jk 0.0436±0.0005 i 0.047±0.002 j 
BAPN 1.03±0.02 f 0.145±0.001 hi 0.071±0.005 j 
LLSC 0.62±0.04 hi 0.352±0.004 f 1.55±0.04 e 
KAG 0.76±0.05 gh 0.290±0.005 fgh 0.14±0.01 i 
SZCEA 0.20±0.04 kl 0.42±0.04 ef 1.82±0.02 c 
AAF 0.052±0.001 l 0.042±0.005 i 0.032±0.003 j 
Pyc 0.46±0.05 ij 0.171±0.001 ghi 0.047±0.001 j 
Res 1.6±0.1 e 0.68±0.01 d 0.051±0.001 j 
GC 0.84±0.05 fg 0.355±0.003 f 0.9±0.1 g 
AA 0.21±0.04 kl 0.0614±0.0005 i 0.049±0.004 j 
GBGT 0.18±0.05 kl 0.556±0.002 de 1.70±0.04 d 
GM 3.7±0.1 a 3.61±0.01 a 1.43±0.05 f 
VRFR 3.2±0.4 b 0.98±0.02 c 0.46±0.01 h 
EA 1.8±0.2 d 0.88±0.01 c 0.51±0.02 h 
EMCO 0.73±0.02 gh 0.636±0.003 d 0.5±0.1 h 
AAF+Res 0.069±0.001 l 0.0568±0.0002 i 0.043±0.003 j 
AAF+EMCO 0.089±0.004 l 0.0690±0.0005 i 0.056±0.002 j 
Res+EMCO 0.844±0.004 fg 0.31±0.01 fg 0.086±0.001 ij 
AAF+Res+EMCO 0.14±0.02 l 0.0738±0.0003 i 0.07±0.01 j 
Standard Trolox 0.041±0.00 l 0.032±0.00 l 0.0043±0.0002 
Standard -Tocopherol 0.040±0.002 0.0695±0.0005 0.0050±0.0006 
 
EC50: sample concentration providing 50% of antioxidant activity in DPPH and TBARS assays, or 0.5 of absorbance at 690 nm in reducing 
power assay.  
 
 
 
Table 3. Theoretical
a 
versus experimental values of antioxidant activity of the combined samples of dietary supplements. 
Mixtures 
DPPH scavenging activity EC50 (mg/mL) Reducing power EC50 (mg/mL) TBARS inhibition EC50 (mg/mL) 
Theoretical Experimental Effect Theoretical Experimental Effect Theoretical Experimental Effect 
AAF+Res+EMCO 0.78±0.04 0.14±0.02 S 0.18±0.03 0.07±0.01 S 0.452±0.002 0.0738±0.0003 S 
AAF+Res 0.81±0.05 0.069±0.001 S 0.041±0.001 0.043±0.003 A 0.361±0.001 0.0568±0.0002 S 
AAF+EMCO 0.39±0.01 0.089±0.004 S 0.25±0.04 0.056±0.002 S 0.339±0.002 0.0690±0.0005 S 
Res+EMCO 1.15±0.05 0.844±0.004 S 0.26±0.04 0.086±0.001 S 0.658±0.004 0.31±0.01 S 
a
The theoretical values were obtained considering additive contributions of the individual species. 
A - Additive effect: theoretical and experimental values reveal differences lower than 5%. S - Synergistic effect:  experimental values are more 
than 5% lower for EC50 when compared with theoretical values. AN-Antagonist effect:  experimental values are more than 5% higher for EC50 
then compared with theoretical values. 
 
 Figure 1. Canonical analysis of antioxidant dietary supplements (condensed- pills and 
capsules, infusion bags and combined- mixed samples) based on antioxidant activities 
(DPPH radical scavenging activity, reducing power, and TBARS formation inhibition). 
The two significant functions are plotted. 
  
 
 
